Aspen Pharmacare Holdings Limited
APNHF
$6.23
-$0.90-12.59%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.08% | 4.46% | 7.14% | 5.99% | 4.30% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.08% | 4.46% | 7.14% | 5.99% | 4.30% |
| Cost of Revenue | -1.06% | 3.70% | 6.75% | 8.61% | 10.00% |
| Gross Profit | 1.19% | 5.43% | 7.61% | 2.88% | -2.29% |
| SG&A Expenses | 11.62% | 10.76% | 7.89% | 5.23% | 2.01% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 157.10% | 48.64% | -4.41% | -11.51% | -22.94% |
| Total Operating Expenses | 4.50% | 6.58% | 6.78% | 7.19% | 7.06% |
| Operating Income | -18.62% | -4.06% | 8.55% | 1.50% | -5.55% |
| Income Before Tax | -100.73% | -48.39% | -2.20% | -9.87% | -17.34% |
| Income Tax Expenses | -23.88% | -2.11% | 17.34% | 5.49% | -6.25% |
| Earnings from Continuing Operations | -123.58% | -61.39% | -7.40% | -13.86% | -20.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -123.58% | -61.39% | -7.40% | -13.86% | -20.14% |
| EBIT | -18.62% | -4.06% | 8.55% | 1.50% | -5.55% |
| EBITDA | -14.49% | -1.67% | 9.30% | 2.61% | -4.21% |
| EPS Basic | -123.63% | -61.41% | -7.38% | -13.84% | -20.15% |
| Normalized Basic EPS | -25.98% | -8.07% | 8.03% | 1.09% | -5.83% |
| EPS Diluted | -123.63% | -61.41% | -7.38% | -13.84% | -20.15% |
| Normalized Diluted EPS | -25.98% | -8.07% | 8.03% | 1.09% | -5.83% |
| Average Basic Shares Outstanding | -0.05% | -0.04% | -0.03% | -0.02% | 0.00% |
| Average Diluted Shares Outstanding | -0.05% | -0.04% | -0.03% | -0.02% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -5.64% | 1.83% | 0.18% | 0.20% | 0.22% |